The European Food Safety Authority has launched a call for SMEs and first-time applicants interested in receiving EFSA’s advice on the application requirements for food additives authorisation in the EU market.
A fully equipped pharmaceutical CMC development facility in Priory Park, Hull, is being offered for sale as part of Indivior PLC’s restructuring of its global operations.
Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) announced a funding solicitation targeting the global burden of antimicrobial resistance (AMR).
Circular Bio-based Europe Joint Undertaking (CBE-JU) have published the 2026 call for project proposals. Applications will open for submissions on 23 April 2026 and close on 22 September 2026 at 17:00 Brussels time. There is €170.7 million available in funding and it’s open to UK companies.
